Singapore markets closed

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4610+0.0142 (+3.18%)
At close: 04:00PM EDT
0.4610 0.00 (0.00%)
After hours: 07:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 61.87M
Enterprise value 46.56M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)31.29
Price/book (mrq)3.89
Enterprise value/revenue 23.63
Enterprise value/EBITDA -1.58

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-34.29%
S&P500 52-week change 3-1.04%
52-week high 31.4800
52-week low 30.3100
50-day moving average 30.4794
200-day moving average 30.7446

Share statistics

Avg vol (3-month) 3811.19k
Avg vol (10-day) 3673.63k
Shares outstanding 5149.73M
Implied shares outstanding 6N/A
Float 8148.45M
% held by insiders 10.80%
% held by institutions 18.71%
Shares short (12 May 2022) 47.21M
Short ratio (12 May 2022) 410.46
Short % of float (12 May 2022) 44.85%
Short % of shares outstanding (12 May 2022) 44.81%
Shares short (prior month 13 Apr 2022) 48.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 312 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,713.76%

Management effectiveness

Return on assets (ttm)-37.95%
Return on equity (ttm)-87.00%

Income statement

Revenue (ttm)1.97M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-17.10%
Gross profit (ttm)-4.66M
EBITDA -32.31M
Net income avi to common (ttm)-30.93M
Diluted EPS (ttm)-0.2730
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)17.77M
Total cash per share (mrq)0.12
Total debt (mrq)2.61M
Total debt/equity (mrq)16.39
Current ratio (mrq)2.05
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)-39.87M
Levered free cash flow (ttm)-28.94M